OR WAIT null SECS
September 18, 2008
MannKind and Pfizer (New York) agreed that the former company will help patients who need inhaled insulin switch from Pfizer's "Exubera" medicine to MannKind's "Technosphere Insulin" drug.
September 11, 2008
Also, Human Genome Sciences enters pact with Hospira, Zosano Pharma names Gail Schulze chair and CEO, more...
September 04, 2008
Also, Novartis stops development on "Aurograb," Zealand Pharma appoints David H. Solomon as CEO, more...
September 02, 2008
This year, the employment survey will acknowledge the industry's best employers.
Are hypersanitation trends a result of scaremongering or a lack of faith in medicine?
September 01, 2008
Different chemistries and viscosities of HPMC can be combined to modulate release profile and, in some cases, result in a more robust formulation.
August 27, 2008
The Healthcare Institute of New Jersey (HINJ) released a new research study showing that New Jersey's life-science industry experienced stable growth in 2007.
The deadline for nominations for the Innovations in Pharma Science Awards is here. Check out http://pharmtech.com/Innovations to nominate your company's work in one of five areas by next week
Also, Shire recalls "Daytrana" patch, Chromatide forms Scientific Advisory Board, more...
August 21, 2008
Also, Tekmira will collaborate with Bristol-Myers Squibb, Helicos Biosciences appoints Steve Lombardi CEO, more...